Alendronate/Colecalciferol: A Viewpoint by Michael Kleerekoper and Aysegul Atmaca

Author： Kleerekoper Michael Atmaca Aysegul

ISSN： 1175-6349

Source： Treatments in Endocrinology, Vol.4, Iss.6, 2005-01, pp. : 379-379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alendronate/Colecalciferol

By Reynolds Neil A. Curran Monique P.

Treatments in Endocrinology, Vol. 4, Iss. 6, 2005-01 ,pp. : 371-377

Adis International

Access to resources Recommend Favorite

Alendronate for the Treatment of Osteoporosis in Men

By Adami S. Prizzi R. Colapietro F.

Calcified Tissue International, Vol. 69, Iss. 4, 2001-10 ,pp. : 239-241

Springer Publishing Company

Access to resources Recommend Favorite

Persistence of weekly alendronate: a real-world study in Croatia

By Grazio Simeon Babic-Naglic Durda Kehler Tatjana Curkovic Bozidar

Clinical Rheumatology, Vol. 27, Iss. 5, 2008-05 ,pp. : 651-653

Springer Publishing Company

Access to resources Recommend Favorite

A European View-Point on NSF

Current Rheumatology Reviews, Vol. 6, Iss. 3, 2010-08 ,pp. : 184-188

Bentham Science Publishers

Access to resources Recommend Favorite

Erratum to: Risk of Upper Gastrointestinal Tract Events in Risedronate Users Switched to Alendronate

By Ralston Stuart

Calcified Tissue International, Vol. 87, Iss. 6, 2010-12 ,pp. : 550-550

Springer Publishing Company

Access to resources Recommend Favorite